BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15933486)

  • 1. Etanercept, anticytokines and mania.
    Kaufman KR
    Int Clin Psychopharmacol; 2005 Jul; 20(4):239-41. PubMed ID: 15933486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked hypertriglyceridemia upon treatment with etanercept.
    Haroon M; Devlin J
    Joint Bone Spine; 2009 Oct; 76(5):570-1. PubMed ID: 19303341
    [No Abstract]   [Full Text] [Related]  

  • 3. Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis.
    Kowalzick L; Bertolini J; Baumann C; Walther B; Truhm B; Eickenscheidt L
    J Dtsch Dermatol Ges; 2013 May; 11(5):447-9. PubMed ID: 23343137
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
    Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of psoriatic arthritis with TNF alpha-antagonists].
    Antoni C; Manger B
    Z Rheumatol; 2003 Jun; 62(3):235-9. PubMed ID: 12827399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etanercept: an evolving role in psoriasis and psoriatic arthritis.
    Prodanovich S; Ricotti C; Glick BP; Inverardi L; Leonardi CL; Kerdel F
    Am J Clin Dermatol; 2010; 11 Suppl 1():3-9. PubMed ID: 20586498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus.
    Mikhail M; Weinberg JM; Smith BL
    Arch Dermatol; 2008 Apr; 144(4):453-6. PubMed ID: 18427038
    [No Abstract]   [Full Text] [Related]  

  • 8. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
    Paul C; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
    [No Abstract]   [Full Text] [Related]  

  • 9. Etanercept in the treatment of severe, resistant psoriatic arthritis: continued efficacy and changing patterns of use after two years.
    Yazici Y; Erkan D; Lockshin MD
    Clin Exp Rheumatol; 2002; 20(1):115. PubMed ID: 11892697
    [No Abstract]   [Full Text] [Related]  

  • 10. Etanercept is safely used for treating psoriatic arthritis in a patient complicated with type 1 hereditary angioedema.
    Umegaki N; Kira M; Horiuchi T; Itoi S; Tani M; Yokomi A; Tanemura A; Miyahara H; Hatanaka M; Kitamura H; Kitano E; Katayama I
    Mod Rheumatol; 2012 Nov; 22(6):928-30. PubMed ID: 22310967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From wheels to feet: a dramatic response of severe chronic psoriatic arthritis to etanercept.
    ElKayam O; Yaron M; Caspi D
    Ann Rheum Dis; 2000 Oct; 59(10):839. PubMed ID: 11203155
    [No Abstract]   [Full Text] [Related]  

  • 12. One million U.S. adults may suffer from psoriatic arthritis.
    Dermatol Nurs; 2002 Jun; 14(3):207-8. PubMed ID: 12099074
    [No Abstract]   [Full Text] [Related]  

  • 13. [Etanercept].
    Mühlhäuser U; Münzel F; Eschenhagen T
    Dtsch Med Wochenschr; 2003 Aug; 128(34-35):1775-8. PubMed ID: 12934172
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors.
    Mease PJ
    Ann Rheum Dis; 2002 Apr; 61(4):298-304. PubMed ID: 11874829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of etanercept in lymphedema associated with psoriatic arthritis.
    Lekpa FK; Economu-Dubosc A; Fevre C; Claudepierre P; Chevalier X
    J Rheumatol; 2009 Jan; 36(1):207-8. PubMed ID: 19208540
    [No Abstract]   [Full Text] [Related]  

  • 16. Pityriasis rosea during etanercept therapy.
    Guarneri C; Polimeni G; Nunnari G
    Eur Rev Med Pharmacol Sci; 2009; 13(5):383-7. PubMed ID: 19961045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriatic onychopachydermoperiostitis: improvement with etanercept.
    Dans M; Hivnor C; van Voorhees AS
    Br J Dermatol; 2005 Oct; 153(4):858-9. PubMed ID: 16181482
    [No Abstract]   [Full Text] [Related]  

  • 18. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence-based practice by biased information from systematic reviews: the case of etanercept and infliximab for the treatment of psoriatic arthritis.
    Corrao S; Puleo A; Pistone G; Calvo L; Scaglione R; Licata G
    Clin Exp Rheumatol; 2008; 26(1):164; author reply 165. PubMed ID: 18328174
    [No Abstract]   [Full Text] [Related]  

  • 20. Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis.
    Aboulafia DM; Bundow D; Wilske K; Ochs UI
    Mayo Clin Proc; 2000 Oct; 75(10):1093-8. PubMed ID: 11040859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.